Skip to main navigation Skip to search Skip to main content

Pathological aspects of lipid peroxidation

  • Anne Negre-Salvayre*
  • , Nathalie Auge
  • , Victoria Ayala
  • , Huveyda Basaga
  • , Jordi Boada
  • , Rainer Brenke
  • , Sarah Chapple
  • , Guy Cohen
  • , Janos Feher
  • , Tilman Grune
  • , Gabriella Lengyel
  • , Giovanni E. Mann
  • , Reinald Pamplona
  • , Giuseppe Poli
  • , Manuel Portero-Otin
  • , Yael Riahi
  • , Robert Salvayre
  • , Shlomo Sasson
  • , Jose Serrano
  • , Ofer Shamni
  • Werner Siems, Richard C.M. Siow, Ingrid Wiswedel, Kamelija Zarkovic, Neven Zarkovic
*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

397 Scopus citations

Abstract

Lipid peroxidation (LPO) product accumulation in human tissues is a major cause of tissular and cellular dysfunction that plays a major role in ageing and most age-related and oxidative stress-related diseases. The current evidence for the implication of LPO in pathological processes is discussed in this review. New data and literature review are provided evaluating the role of LPO in the pathophysiology of ageing and classically oxidative stress-linked diseases, such as neurodegenerative diseases, diabetes and atherosclerosis (the main cause of cardiovascular complications). Striking evidences implicating LPO in foetal vascular dysfunction occurring in pre-eclampsia, in renal and liver diseases, as well as their role as cause and consequence to cancer development are addressed.

Original languageEnglish
Pages (from-to)1125-1171
Number of pages47
JournalFree Radical Research
Volume44
Issue number10
DOIs
StatePublished - Oct 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • 4-Hydroxynonenal
  • 4-hydroxydodecadienal
  • 4-hydroxynonenal
  • Alzheimer ' s disease
  • HELLP syndrome
  • IUGR
  • Nrf2
  • Oxidative stress
  • Parkinson ' s disease
  • advanced glycation end-products
  • amyotrophic lateral sclerosis
  • antioxidant enzymes
  • atherosclerosis
  • cancer
  • cell signalling
  • diabetes
  • diabetes complications
  • fatty liver
  • foetal endothelium
  • glutathione
  • hyperglycaemia
  • lipid peroxidation
  • liver disease
  • lymphoedema
  • neurodegenerative diseases
  • oxidative homeostasis
  • oxidized phospholipids
  • oxysterol
  • pre-eclampsia
  • reactive oxygen species
  • redox equilibrium
  • redox signaling
  • renal diseases

Fingerprint

Dive into the research topics of 'Pathological aspects of lipid peroxidation'. Together they form a unique fingerprint.

Cite this